AFP and cancer: In 2012, a first report demonstrated that an RNA aptamer against alpha-fetoprotein (AFP) was able to detect cancer cells, inhibit the proliferation of AFP-associated HepG2 cells and decrease the gene expressions of the c-jun and c-fos oncogenes [83].